GE HealthCare Technologies (NASDAQ:GEHC) Price Target Raised to $98.00

GE HealthCare Technologies (NASDAQ:GEHC) had its price objective raised by Evercore from $95.00 to $98.00 in a report published on Thursday morning,Benzinga reports. Evercore currently has an outperform rating on the stock.

Several other equities analysts have also recently issued reports on the company. Barclays started coverage on GE HealthCare Technologies in a report on Monday, October 13th. They issued an “equal weight” rating and a $86.00 price objective for the company. The Goldman Sachs Group reaffirmed a “buy” rating and set a $98.00 price objective on shares of GE HealthCare Technologies in a research note on Friday, January 9th. Jefferies Financial Group boosted their target price on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Thursday, December 11th. Bank of America raised their price target on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research report on Monday, January 5th. Finally, UBS Group lowered shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and increased their target price for the stock from $73.00 to $77.00 in a research note on Thursday, January 15th. Seven analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, GE HealthCare Technologies currently has a consensus rating of “Hold” and a consensus target price of $92.50.

GE HealthCare Technologies Stock Down 2.0%

GEHC stock opened at $80.65 on Thursday. The stock has a market capitalization of $36.76 billion, a PE ratio of 17.69, a price-to-earnings-growth ratio of 2.38 and a beta of 1.08. GE HealthCare Technologies has a 52 week low of $57.65 and a 52 week high of $94.80. The company has a quick ratio of 0.95, a current ratio of 1.37 and a debt-to-equity ratio of 0.91. The firm has a 50 day moving average of $82.73 and a 200 day moving average of $77.55.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. The company had revenue of $5.70 billion during the quarter, compared to analyst estimates of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The firm’s quarterly revenue was up 7.1% on a year-over-year basis. During the same quarter last year, the business posted $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Sell-side analysts forecast that GE HealthCare Technologies will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be paid a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, January 9th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 3.07%.

Institutional Investors Weigh In On GE HealthCare Technologies

Institutional investors have recently bought and sold shares of the company. Empowered Funds LLC raised its holdings in shares of GE HealthCare Technologies by 6.1% during the first quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock valued at $2,328,000 after acquiring an additional 1,665 shares during the last quarter. Acadian Asset Management LLC purchased a new stake in shares of GE HealthCare Technologies during the first quarter worth approximately $259,000. Wealthcare Advisory Partners LLC increased its position in shares of GE HealthCare Technologies by 18.6% during the second quarter. Wealthcare Advisory Partners LLC now owns 4,682 shares of the company’s stock worth $347,000 after purchasing an additional 733 shares in the last quarter. Valeo Financial Advisors LLC raised its stake in GE HealthCare Technologies by 36.4% in the 2nd quarter. Valeo Financial Advisors LLC now owns 10,363 shares of the company’s stock valued at $768,000 after purchasing an additional 2,766 shares during the last quarter. Finally, KLP Kapitalforvaltning AS lifted its holdings in GE HealthCare Technologies by 15.9% in the 2nd quarter. KLP Kapitalforvaltning AS now owns 181,479 shares of the company’s stock valued at $13,442,000 after purchasing an additional 24,900 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.